CAD & Atherosclerosis
From the Journals
Study points to causal role for Lp(a) in atrial fibrillation
The relation is relatively modest but strongly argues for increased testing of Lp(a) and adding atrial fibrillation as a secondary outcome to...
From the Journals
Bariatric surgery cuts cardiovascular events, even in seniors
In persons with obesity, even those aged 65-75 years of age, bariatric surgery can reduce long-term cardiovascular events, such as heart failure,...
From the Journals
The best statins to lower non-HDL cholesterol in diabetes?
Rosuvastatin, simvastatin, and atorvastatin were most effective in reducing levels of non-HDL cholesterol in people with diabetes in a network...
From the Journals
Aspirin exposure fails to reduce cardiovascular event risk
Post hoc analysis showed no additional benefit from aspirin in reducing cardiovascular risk for hypertension patients with controlled systolic...
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...
Conference Coverage
FFR not better, just different from IVUS for revascularizing intermediate stenoses
In a head-to-head comparison in the FLAVOUR trial, IVUS- and FFR-guided PCI produced similar outcomes but had differing strengths.
Guidelines
AHA statement addresses CVD risk in NAFLD
The American Heart Association has issued a new scientific statement addressing cardiovascular risk in nonalcoholic fatty liver disease.
From the Journals
Erectile dysfunction drugs linked to ocular conditions
“Generally speaking, if [patients taking these agents] experience visual problems or changes in vision, then these drugs may be the culprits, and...
From the Journals
Study: Physical fitness in children linked with concentration, quality of life
VO2max scores were strongly associated with health-related quality of life.
From the Journals
Novel tool could calculate CVD risk in T2DM
A blood pressure polygenic risk score using 1,000 genetic variants has shown the potential to calculate cardiovascular risk in people with...
Conference Coverage
Early PCSK9 inhibition in AMI yields plaque regression
‘Go early and go low’ is an expert’s response to the imaging results from PACMAN-AMI showing plaque reduction after AMI patients received...